Plethico Pharmaceuticals, established in 1991, is a leading global healthcare / pharmaceutical company with a strong emphasis on herbal and neutraceutical segments. The company focused on manufacturing and marketing a range of branded generic pharmaceutical formulations, has rapidly evolved and now engages in the manufacture, marketing and distribution of pharmaceutical and allied healthcare products in the neutraceutical and herbal segments in India and internationally. Domestically, Plethico operates in the segments of sports nutrition, confectionary and OTC, in India.
In addition to India in the OTC segment, Plethico is also a leading player in the Commonwealth of Independent States (CIS), Africa, South East Asia, Latin America and in the GCC for its Travisil range of products. With the recent acquisition of Natrol – a leading manufacturer and marketer of branded nutritional products in the United States, Plethico has now expanded its global footprint to the regulated markets of the United States and Europe.
With over 400 product approvals, operations in more than 25 countries, and exports to over 45 countries, Plethico continues to build on its strength of developing synergistic alliances and strengthen its supply chain management, particularly for the exciting and challenging overseas markets.
Plethico has established itself as a dominant player in regions including the CIS, Africa, Latin America and South East Asia. Fully owned subsidiaries, joint ventures, acquisitions and Plethico’s own distribution networks have enabled the company to emerge as a strong competitor in the global markets.
Product range of the company includes:
Different divisions of the company :Nutriscience
Achievements/ recognition :
Future plans :
Plethico is planning to enter the areas of immunomodulation, gynecological disorders and antioxidants in the near future.
The company also plans to manufacture and market Natrol’s top brands in India and also make them available in the stronghold semi-regulated markets. Simultaneously, It plans to launch its leading homegrown brand Travisil and Actifresh SF in the US market.